The hepatitis A virus (HAV) is a leading cause of acute viral hepatitis worldwide. It is
transmitted mainly by direct contact with patients who have been infected or by ingesting …

Background Infectious disease epidemiology is continuously shifting. While travel has been
disrupted by the COVID-19 pandemic and travel-related epidemiological research …

Abstract Problem/Condition: Adults are at risk for illness, hospitalization, disability and, in
some cases, death from vaccine-preventable diseases, particularly influenza and …

Hepatitis A is a vaccine-preventable, communicable disease of the liver caused by the
hepatitis A virus (HAV). The infection is transmitted via the fecal-oral route, usually from …

These guidelines for the treatment of persons who have or are at risk for sexually transmitted
infections (STIs) were updated by CDC after consultation with professionals knowledgeable …

Hepatitis A virus (HAV) infections continue to represent a significant disease burden causing
approximately 200 million infections, 30 million symptomatic illnesses and 30,000 deaths …

Viral hepatitis results in 1.4 million deaths annually. The World Health Organization (WHO)
set an ambitious target to eliminate viral hepatitis by 2030, but significant challenges remain …

Hepatitis A epidemiology in the United States has shifted as a result of recent and ongoing
outbreaks associated with person-to-person transmission. During August 1, 2016 …

Este artigo aborda as hepatites virais, tema tratado no Protocolo Clínico e Diretrizes
Terapêuticas para Atenção Integral às Pessoas com Infecções Sexualmente Transmissíveis …

To reduce morbidity and mortality associated with vaccine-preventable diseases (VPD), it is
imperative that vaccination programs are implemented and prioritized throughout all stages …